Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cardiovascular Diabetology|March 27, 2026
Dapagliflozin-induced integrated improvements in left ventricular diastole, endothelial function, and arterial load: a randomized clinical trialSheila T Kimura-Medorima, Daniela C Oliveira, Ikaro Breder, et al.Cardiovascular Diabetology|August 6, 2022
Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trialAndrei C Sposito, Ikaro Breder, Joaquim Barreto, et al.Cardiovascular Diabetology|March 27, 2021
Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trialAndrei C Sposito, Ikaro Breder, Alexandre A S Soares, et al.Current Medical Research and Opinion|February 17, 2022
Rationale and design of the Brazilian diabetes study: a prospective cohort of type 2 diabetesJoaquim Barreto, Vaneza Wolf, Isabella Bonilha, et al.Diabetology & Metabolic Syndrome|August 7, 2019
Assessment of dapagliflozin effect on diabetic endothelial dysfunction of brachial artery (ADDENDA-BHS2 trial): rationale, design, and baseline characteristics of a randomized controlled trialRiobaldo M R Cintra, Alexandre A S Soares, Ikaro Breder, et al.Immunology|April 23, 2025
Obesity-Induced Metabolic Priming Exacerbates SARS-CoV-2 InflammationGustavo Gastão Davanzo, Bianca Gazieri Castelucci, Gabriela Fabiano de Souza, et al.Pageof 2